NRXN2 Homozygous Variant Identified in a Family with Global Developmental Delay, Severe Intellectual Disability, EEG Abnormalities and Speech Delay: A new Syndrome?
Clinical EEG and Neuroscience · 2025
DOI: 10.1177/15500594241309948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical EEG and Neuroscience, 2025. Verfasst von Derya Karaer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Pamukkale University Faculty of Medicine, Denizli, Turkiye. Hauptthemen laut MEDLINE: Intellectual Disability, Developmental Disabilities, Language Development Disorders, Nerve Tissue Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
This study aims to characterize the clinical phenotype of a family with two siblings exhibiting neurological manifestations, utilizing whole exome sequencing (WES) to identify potential pathogenic variants within the NRXN2 gene.
Methods
A consanguineous family with two affected siblings displaying developmental delay, severe intellectual disability, epilepsy, and speech delay was examined. WES was performed on DNA samples from affected and unaffected family members, followed by a comprehensive bioinformatics analysis. In-silico tools were employed for variant interpretation and structural modeling of the NRXN2 protein. Clinical and genetic data were integrated to elucidate the potential impact of the identified variant.
Results
WES revealed a novel homozygous missense variant (c.1475T>G, p.Leu492Arg) in the NRXN2 gene in both affected siblings. This variant was absent in healthy family members and public databases. In-silico analysis predicted a detrimental effect on protein function. Parental segregation confirmed heterozygous carrier status. The variant was classified as ‘Likely Pathogenic’ based on ACMG/AMP criteria.
Conclusion
This study identifies a novel homozygous missense variant in NRXN2 associated with global developmental delay, severe intellectual disability, speech delay and epilepsy. The findings underscore the critical role of NRXN2 in neurodevelopment and highlight the potential implications of genetic variations within this gene in neurodevelopmental disorders. Further research and functional validation are warranted to deepen our understanding of NRXN2 -related disorders and explore potential therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Pamukkale University Faculty of Medicine, Denizli, Turkiye.
- Department of Pediatric Neurology, Gaziantep University Faculty of Medicine, Gaziantep, Turkiye.
ORCID-Profile: Kadri Karaer
Zitieren
APA
Karaer, D., Özçelik, A. A., & Karaer, K. (2025). NRXN2 Homozygous Variant Identified in a Family with Global Developmental Delay, Severe Intellectual Disability, EEG Abnormalities and Speech Delay: A new Syndrome?. Clinical EEG and Neuroscience. https://doi.org/10.1177/15500594241309948
Vancouver
Karaer D, Özçelik AA, Karaer K. NRXN2 Homozygous Variant Identified in a Family with Global Developmental Delay, Severe Intellectual Disability, EEG Abnormalities and Speech Delay: A new Syndrome?. Clinical EEG and Neuroscience. 2025. doi:10.1177/15500594241309948
BibTeX
@article{Karaer2025,
author = {Karaer, Derya and Özçelik, Ayşe Aysima and Karaer, Kadri},
title = {NRXN2 Homozygous Variant Identified in a Family with Global Developmental Delay, Severe Intellectual Disability, EEG Abnormalities and Speech Delay: A new Syndrome?},
journal = {Clinical EEG and Neuroscience},
year = {2025},
doi = {10.1177/15500594241309948}
}
EUVIMED